Tesla
TSLA
NVIDIA
NVDA
Palantir
PLTR
4
BigBear.ai Holdings
BBAI
5
Advanced Micro Devices
AMD
US Stock MarketDetailed Quotes
TMCI Treace Medical Concepts
- 8.940
- -0.190-2.08%
Close Feb 28 16:00 ET
- 8.940
- 0.0000.00%
Post 16:20 ET
559.81MMarket Cap-9.93P/E (TTM)
9.030High8.185Low847.17KVolume8.880Open9.130Pre Close7.47MTurnover1.78%Turnover RatioLossP/E (Static)62.62MShares13.80052wk High4.96P/B424.49MFloat Cap3.92052wk Low--Dividend TTM47.48MShs Float37.170Historical High--Div YieldTTM9.26%Amplitude3.920Historical Low8.817Avg Price1Lot Size
Treace Medical Concepts Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -7.50%-37.17M | -890.79%-4.21M | -24.48%-11.84M | -66.73%-13.9M | 58.16%-7.22M | -12.81%-34.58M | 109.93%532K | -27.13%-9.51M | 21.11%-8.34M | -138.35%-17.26M |
| Net income from continuing operations | -12.55%-55.74M | 92.02%-501K | 12.33%-15.36M | -72.81%-21.21M | -38.81%-18.68M | -15.68%-49.53M | -42.36%-6.28M | -44.41%-17.52M | 28.80%-12.27M | -48.89%-13.45M |
| Depreciation and amortization | 57.31%8.42M | 26.46%2.24M | 37.92%2.16M | 93.24%2.12M | 106.60%1.91M | 150.91%5.35M | 92.91%1.77M | 240.74%1.56M | 158.87%1.1M | 176.65%924K |
| Other non cash items | 7.49%3.19M | 207.20%2.18M | -157.28%-480K | -0.95%733K | 11.82%757K | 6.16%2.96M | 20.61%708K | -11.23%838K | -15.81%740K | 77.69%677K |
| Change In working capital | -161.04%-25.43M | -1,022.16%-17.01M | -868.25%-6M | -240.29%-3.98M | 119.86%1.56M | -67.72%-9.74M | 73.84%-1.52M | -20.31%781K | -61.24%-1.17M | -2,814.13%-7.84M |
| -Change in receivables | 38.86%-5.69M | -28.09%-17.19M | -45.95%1.21M | 229.84%2.48M | 106.20%7.82M | 15.74%-9.3M | -20.95%-13.42M | 208.81%2.24M | -343.49%-1.91M | 49.21%3.79M |
| -Change in inventory | -1.65%-10.01M | 6,401.49%4.36M | 27.37%-2.33M | -54.17%-5.42M | -107.43%-6.62M | -12.30%-9.85M | 102.44%67K | 11.22%-3.21M | -89.08%-3.52M | -478.77%-3.19M |
| -Change in prepaid assets | 280.66%2.19M | 840.66%1.35M | 6.53%653K | 347.79%1.68M | -55.24%-1.5M | -81.14%-1.21M | -146.67%-182K | 3,326.32%613K | 70.16%-678K | -178.10%-963K |
| -Change in payables and accrued expense | -186.17%-9.22M | -125.93%-3.28M | -463.08%-6.23M | -163.69%-2.1M | 134.44%2.4M | -8.88%10.7M | 64.33%12.64M | -71.20%1.72M | 151.64%3.3M | -115.69%-6.96M |
| -Change in other current assets | ---330K | ---18K | ---- | ---- | --0 | --0 | --0 | ---- | ---- | 48.51%-69K |
| -Change in other current liabilities | -1,978.15%-2.47M | -277.60%-2.33M | 298.96%1.14M | -140.90%-634K | -37.45%-657K | -103.87%-119K | -1,611.11%-616K | -179.86%-575K | -38.61%1.55M | -259.40%-478K |
| -Change in other working capital | 142.50%97K | ---- | ---- | 53.85%20K | 328.00%107K | --40K | --0 | --2K | --13K | --25K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -7.50%-37.17M | -890.79%-4.21M | -24.48%-11.84M | -66.73%-13.9M | 58.16%-7.22M | -12.81%-34.58M | 109.93%532K | -27.13%-9.51M | 21.11%-8.34M | -138.35%-17.26M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 143.51%35.38M | -31.68%3.42M | 25.36%5.76M | 315.23%22.43M | 104.67%3.76M | -6.25%-81.3M | 107.82%5.01M | 178.49%4.6M | -101.68%-10.42M | -5,334.17%-80.48M |
| Net PPE purchase and sale | -1.18%-11.59M | -36.74%-3.07M | 18.22%-2.86M | 59.13%-1.73M | -165.70%-3.93M | 22.78%-11.46M | 3.60%-2.25M | 40.23%-3.5M | 18.13%-4.23M | 0.20%-1.48M |
| Net business purchase and sale | --0 | --0 | --0 | ---- | ---- | ---20M | --0 | --0 | ---- | ---- |
| Net investment purchase and sale | 194.24%46.97M | -10.48%6.5M | 6.52%8.63M | 74.99%24.16M | 109.73%7.69M | 19.19%-49.84M | 111.76%7.26M | --8.1M | --13.81M | ---79M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 143.51%35.38M | -31.68%3.42M | 25.36%5.76M | 315.23%22.43M | 104.67%3.76M | -6.25%-81.3M | 107.82%5.01M | 178.49%4.6M | -101.68%-10.42M | -5,334.17%-80.48M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -99.85%160K | -84.24%26K | -94.97%8K | -73.64%311K | -100.17%-185K | 425.73%109.38M | -44.44%165K | -54.96%159K | -93.72%1.18M | 7,762.90%107.88M |
| Net issuance payments of debt | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net common stock issuance | --0 | --0 | --0 | --0 | --0 | --107.53M | --0 | --0 | --0 | --107.53M |
| Proceeds from stock option exercised by employees | -77.10%428K | -67.98%57K | -94.97%8K | -73.64%311K | -85.23%52K | -14.54%1.87M | -40.07%178K | -54.96%159K | 615.15%1.18M | -74.34%352K |
| Net other financing activities | -1,961.54%-268K | ---31K | --0 | --0 | ---237K | 98.69%-13K | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -99.85%160K | -84.24%26K | -94.97%8K | -73.64%311K | -100.17%-185K | 425.73%109.38M | -44.44%165K | -54.96%159K | -93.72%1.18M | 7,762.90%107.88M |
| Net cash flow | ||||||||||
| Beginning cash position | -33.33%12.98M | 66.39%12.11M | 51.07%18.18M | -68.48%9.33M | -33.33%12.98M | -81.60%19.47M | -91.78%7.28M | -88.15%12.04M | -69.93%29.61M | -81.60%19.47M |
| Current changes in cash | 74.86%-1.63M | -113.32%-760K | -27.62%-6.07M | 150.33%8.85M | -135.98%-3.65M | 92.48%-6.49M | 108.26%5.7M | 63.37%-4.76M | -676.33%-17.58M | 237.96%10.14M |
| End cash Position | -12.57%11.35M | -12.57%11.35M | 66.39%12.11M | 51.07%18.18M | -68.48%9.33M | -33.33%12.98M | -33.33%12.98M | -91.78%7.28M | -88.15%12.04M | -69.93%29.61M |
| Free cash flow | -5.92%-48.76M | -324.30%-7.28M | -12.99%-14.71M | -24.35%-15.63M | 40.50%-11.15M | -1.20%-46.03M | 77.69%-1.72M | 2.44%-13.01M | 20.13%-12.57M | -114.82%-18.74M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |